Covered recipient · General Payments record
FATIMA SAMIR BEYDOUN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,694.28
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $490.01 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.12 | 11 |
| PFIZER INC. | $119.82 | 6 |
| Novo Nordisk AS | $84.10 | 4 |
| Acerta Pharma LLC | $48.61 | 3 |
| Lilly USA, LLC | $46.81 | 3 |
| GlaxoSmithKline, LLC. | $39.02 | 2 |
| Exact Sciences Corporation | $14.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.12 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319096 | CMS |
| ABBVIE INC. | $3.94 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319098 | CMS |
| ABBVIE INC. | $28.76 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319100 | CMS |
| ABBVIE INC. | $3.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319102 | CMS |
| ABBVIE INC. | $4.34 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319104 | CMS |
| ABBVIE INC. | $15.13 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319106 | CMS |
| ABBVIE INC. | $9.01 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319108 | CMS |
| ABBVIE INC. | $10.36 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319110 | CMS |
| ABBVIE INC. | $19.73 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319112 | CMS |
| ABBVIE INC. | $12.34 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319114 | CMS |
| ABBVIE INC. | $23.75 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319116 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.19 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105281734 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.73 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104318162 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.69 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104595302 | CMS |
| Exact Sciences Corporation | $14.53 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114556756 | CMS |
| GlaxoSmithKline, LLC. | $22.23 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116273674 | CMS |
| GlaxoSmithKline, LLC. | $16.79 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116496262 | CMS |
| Lilly USA, LLC | $16.73 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972479 | CMS |
| Lilly USA, LLC | $15.10 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972260 | CMS |
| Lilly USA, LLC | $14.98 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134963923 | CMS |
| Novo Nordisk Inc | $21.28 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096576129 | CMS |
| Novo Nordisk Inc | $20.38 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097614156 | CMS |
| Novo Nordisk Inc | $21.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097178536 | CMS |
| Novo Nordisk Inc | $21.19 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096987057 | CMS |
| PFIZER INC. | $19.84 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131444099 | CMS |
| PFIZER INC. | $19.56 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131425513 | CMS |
| PFIZER INC. | $17.53 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131681821 | CMS |
| PFIZER INC. | $24.75 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132010846 | CMS |
| PFIZER INC. | $20.61 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131872431 | CMS |
| PFIZER INC. | $17.53 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131929606 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.